pyrazinamide has been researched along with Keratoconjunctivitis in 1 studies
pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.
Keratoconjunctivitis: Simultaneous inflammation of the cornea and conjunctiva.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sharma, K | 1 |
| Kalakoti, P | 1 |
| Juneja, R | 1 |
| Sahu, S | 1 |
| Singh, V | 1 |
| Subramanian, PS | 1 |
1 other study available for pyrazinamide and Keratoconjunctivitis
| Article | Year |
|---|---|
Re-emphasizing Thygeson's warning: conjunctival phlyctenulosis as presenting sign of impending clinical tuberculosis.
Topics: Antitubercular Agents; Blood Sedimentation; Child; Drug Therapy, Combination; Ethambutol; Female; Hu | 2014 |